By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

National Cancer Institute (NCI) 

NCI Public Inquiries Office
Building, 31, Room 10A03
31 Center Drive, MSC 2

Bethesda  Maryland  20892-2580  U.S.A.
Phone: 301-435-3848 Fax:


SEARCH JOBS




Collaborations

Maxygen, Inc. 

Genzyme General 

PanVera LLC 

Panacos Pharmaceuticals Inc.  Panacos has a CRADA with leading scientists at the National Cancer Institute to study the mechanism of HIV maturation inhibitors and to discover new antiviral drugs.





Company News
Corvida Medical Launches Research Study With Funding And Support From The National Cancer Institute 12/5/2014 11:16:21 AM
OncoMed Pharmaceuticals, Inc. (OMED) Presents New Clinical And Biomarker Data From Its Tarextumab And Demcizumab Clinical Trials At The European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium 11/24/2014 12:55:50 PM
Merrimack Pharmaceuticals Inc. (MACK) Presents On Multiple Programs At The 26th European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium On Molecular Targets And Cancer Therapeutics 11/21/2014 2:46:31 PM
3-V Biosciences Announces Presentation Of First Human Clinical Data For Lead Oral FASN Inhibitor Candidate At European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research 2014 11/19/2014 3:38:49 PM
Champions Oncology, Inc. (CSBR) Release: Presentations At 26th Champions Oncology, Inc. (CSBR)-European Organization for Research and Treatment of Cancer-National Cancer Institute Symposium Highlight Champions Oncology TumorGrafts' Ability To Evaluate Immune-Modulating Therapies And Guide Clinical Development Strategies 11/19/2014 12:15:39 PM
OncoMed Pharmaceuticals, Inc. (OMED) Presents Biomarker-Focused Clinical Data From Phase 1a Trial Of Anti-Notch1 (OMP-52M51) In Oral Plenary Session At The 26th OncoMed Pharmaceuticals, Inc. (OMED)-European Organization for Research and Treatment of Cancer-National Cancer Institute Symposium 11/19/2014 9:35:09 AM
Debiopharm Group Presents Advances Of Two Key Oncology Clinical Programs At The 26th European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium In Barcelona 11/18/2014 1:12:12 PM
Epic Sciences To Present Data On A Combination CTC And cfDNA Assay For Molecular Targets Of Non-Small Cell Lung Cancer Therapies At The 26th EORTC-National Cancer Institute-American Association for Cancer Research Symposium 11/17/2014 11:57:43 AM
Organic Vaccines Plc - Agreements With NIH And National Cancer Institute 11/17/2014 11:31:34 AM
Merrimack Pharmaceuticals Inc. (MACK) To Present Advances On Targeted Cancer Molecules At The 2014 American Association for Cancer Research-National Cancer Institute-European Organization for Research and Treatment of Cancer International Conference 11/14/2014 10:14:09 AM
12345678910...
//-->